In addition, mannan-binding lectin serine protease (MASP2), a serum protease that plays an important role in the activation of the complement system via mannose-binding lectin, was downregulated in the sEV fractions of the bladder cancer patients. The gene discussed is MASP2; the disease is urinary bladder carcinoma.